+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
MicroRNA Sponge Service Market - Global Forecast 2026-2032- Product Image
MicroRNA Sponge Service Market - Global Forecast 2026-2032- Product Image
Sale

MicroRNA Sponge Service Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6139509
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The MicroRNA Sponge Service Market is projected to reach USD 106.60 Million in 2026. It is expected to continue growing at a CAGR of 10.32%, reaching USD 185.48 Million by 2032.

MicroRNA Sponge Services Support Targeted Gene-Regulation Research

MicroRNA sponge services provide designed RNA constructs that sequester selected microRNAs, enabling researchers to investigate post-transcriptional regulation, pathway interactions, and disease mechanisms. The field sits at the intersection of molecular biology, functional genomics, synthetic biology, and translational research. Demand is shaped by the need for reproducible construct design, validated biological activity, suitable delivery systems, and dependable analytical workflows.

Validation, Delivery, and Multiplexing Are Reshaping Service Requirements

The service landscape is shifting from construct production alone toward integrated workflows that connect sequence design, vector selection, transfection or transduction, expression confirmation, and functional validation. Researchers increasingly require evidence that a sponge selectively modulates its intended microRNA without introducing material off-target effects. Multiplex designs, inducible systems, tissue-specific expression, and compatibility with organoid, primary-cell, and in vivo models are also expanding technical requirements.

Artificial Intelligence Accelerates Design and Interpretation but Requires Experimental Controls

Artificial intelligence can support microRNA target prioritization, sequence optimization, secondary-structure analysis, literature synthesis, and interpretation of high-dimensional expression data. Its practical value depends on curated training data, transparent model assumptions, and independent laboratory validation. AI-generated designs should therefore be assessed through appropriate controls, dose-response testing, orthogonal assays, and replication across relevant biological systems rather than accepted solely on computational scores.

Regional Capabilities Differ by Research Infrastructure and Regulatory Context

North America combines strong biomedical research infrastructure with broad access to advanced sequencing, viral-vector, and translational platforms. Europe benefits from coordinated research networks and established molecular-biology capabilities, while the European Union places particular emphasis on data governance, biosafety, and responsible research practices. Asia-Pacific is supported by expanding genomics capacity and growing biotechnology activity, with Australia, China, India, Japan, and South Korea contributing distinct academic and industrial capabilities. Latin America is developing specialized research capacity, particularly through university and public-sector laboratories, while Brazil and Mexico remain important hubs. The Middle East is strengthening precision-biology infrastructure through research investment and collaboration, and Africa continues to build capability through selected academic, clinical, and genomics initiatives.

International Research Groups Create Varied Adoption and Collaboration Patterns

ASEAN institutions can benefit from regional collaboration, shared core facilities, and capacity-building in molecular assays. BRICS members represent diverse research ecosystems, with opportunities for joint studies, local production, and cross-border method development. European Union programs support multicenter research and harmonized standards, while G7 environments generally offer mature infrastructure, extensive translational networks, and rigorous governance expectations. GCC countries are investing in biomedical capability and precision-health programs, creating demand for specialized services and training. NATO countries may draw on established life-science networks and dual-use research safeguards, although participation and requirements vary substantially among member states.

Country-Level Priorities Reflect Distinct Scientific Strengths and Operating Conditions

The United States and Canada offer deep expertise in functional genomics, delivery technologies, and translational validation. The United Kingdom, Germany, France, Italy, and Spain contribute strong academic and clinical research networks, with European compliance and data-management requirements shaping project execution. China, Japan, and South Korea have substantial capabilities in sequencing, synthetic biology, and biomedical engineering. India is expanding cost-efficient research and contract-service capacity, while Australia supports genomics and translational research through established institutions. Brazil and Mexico are important Latin American centers for biomedical investigation. Russia maintains specialized molecular-biology expertise, though collaboration, procurement, and regulatory conditions can affect project design and continuity.

Leaders Should Build Validated, Flexible, and Governance-Ready Service Models

Industry leaders should offer end-to-end workflows that connect design, synthesis, delivery, expression testing, and functional readouts, with clear acceptance criteria at each stage. Standardized controls, orthogonal validation, documented sequence provenance, and transparent reporting can improve reproducibility. Providers should support multiple experimental formats, including cell lines, primary cells, organoids, and carefully governed in vivo studies. Investment in AI should focus on auditable decision support rather than automation without review. Regional partnerships, local technical support, secure data handling, and clear biosafety documentation can further improve adoption across heterogeneous research environments.

Methodology Combines Scientific Literature, Service-Practice Review, and Geographic Triangulation

This executive summary uses a qualitative synthesis of established microRNA biology, molecular-genetics methods, gene-delivery practices, research-service workflows, and publicly documented regional scientific infrastructure. Findings are organized around technical requirements, adoption conditions, artificial-intelligence applications, and geographic research capabilities. Claims are framed conservatively and avoid unsupported quantitative conclusions. Regional, group, and country observations reflect broad differences in infrastructure, governance, collaboration, and research maturity rather than rankings or market measurements.

Reliable Validation Will Define the Next Stage of MicroRNA Sponge Services

MicroRNA sponge services are becoming more valuable as researchers seek controllable tools for dissecting gene-regulatory networks and validating therapeutic hypotheses. The strongest providers will distinguish themselves through biological evidence, adaptable delivery options, reproducible documentation, and responsible use of computational design. Progress will depend on combining AI-assisted prioritization with rigorous experimentation, while regional partnerships and governance-ready operations help translate specialized techniques into dependable research workflows.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. MicroRNA Sponge Service Market, by Service Type
7.1. Introduction
7.2. Design Services
7.2.1. In Silico Design
7.2.2. In Vitro Design
7.3. Functional Screening Services
7.3.1. High-Throughput Screening
7.3.2. Low-Throughput Screening
7.4. Synthesis Services
7.4.1. Oligonucleotide Synthesis
7.4.2. Plasmid Synthesis
7.5. Validation Services
7.5.1. Clinical Validation
7.5.2. Functional Validation
8. MicroRNA Sponge Service Market, by Technology
8.1. Introduction
8.2. Bioinformatics Platforms
8.2.1. Data Analysis Software
8.2.2. Database Access Platforms
8.3. Microarray Analysis
8.3.1. cDNA Arrays
8.3.2. Oligonucleotide Arrays
8.4. Next Generation Sequencing
8.4.1. Illumina Sequencing
8.4.2. Ion Torrent Sequencing
8.5. Quantitative Polymerase Chain Reaction
8.5.1. SYBR Green Assays
8.5.2. TaqMan Assays
9. MicroRNA Sponge Service Market, by Application
9.1. Introduction
9.2. Agricultural Research
9.3. Biomarker Discovery
9.3.1. Diagnostic Biomarkers
9.3.2. Prognostic Biomarkers
9.4. Disease Research
9.4.1. Cancer Research
9.4.2. Cardiovascular Research
9.4.3. Neurological Research
9.5. Drug Discovery
9.5.1. Clinical Trials Support
9.5.2. Preclinical Studies
10. MicroRNA Sponge Service Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.2.1. Government Labs
10.2.2. Universities
10.3. Biotechnology Companies
10.3.1. Mid-Size Biotech
10.3.2. Startups
10.4. Contract Research Organizations
10.4.1. Clinical CROs
10.4.2. Preclinical CROs
10.5. Pharmaceutical Companies
10.5.1. Big Pharma
10.5.2. Small Pharma
11. MicroRNA Sponge Service Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. MicroRNA Sponge Service Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. MicroRNA Sponge Service Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abcam plc
15.2. Addgene, Inc.
15.3. BioBasic Inc.
15.4. Biomics Biotechnologies
15.5. Bioneer Corporation
15.6. Biovector, Inc.
15.7. BioVision, Inc.
15.8. Creative Biogene
15.9. Exiqon A/S
15.10. Genechem Co., Ltd.
15.11. GeneCopoeia Europe
15.12. GeneCopoeia, Inc.
15.13. GenePharma Co., Ltd.
15.14. Genolution, Inc.
15.15. Genomeditech Co., Ltd.
15.16. GenScript Biotech Corporation
15.17. Horizon Discovery Group plc
15.18. Huaan Biotechnology Co., Ltd.
15.19. InvivoGen, Inc.
15.20. Origene Technologies, Inc.
15.21. RiboBio Co., Ltd.
15.22. Sangon Biotech Co., Ltd.
15.23. Takara Bio Inc.
15.24. Thermo Fisher Scientific
15.25. Twist Bioscience Corporation
15.26. VectorBuilder, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global MicroRNA Sponge Service Market, Years Considered for the Study
FIGURE 2. Global MicroRNA Sponge Service Market, Research Design
FIGURE 3. Global MicroRNA Sponge Service Market, Research Framework
FIGURE 4. Global MicroRNA Sponge Service Market, Data Triangulation
FIGURE 5. Global MicroRNA Sponge Service Market Size, 2017-2032 (USD Million)
FIGURE 6. Global MicroRNA Sponge Service Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global MicroRNA Sponge Service Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global MicroRNA Sponge Service Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global MicroRNA Sponge Service Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global MicroRNA Sponge Service Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global MicroRNA Sponge Service Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global MicroRNA Sponge Service Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global MicroRNA Sponge Service Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global MicroRNA Sponge Service Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global MicroRNA Sponge Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global MicroRNA Sponge Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global MicroRNA Sponge Service Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global MicroRNA Sponge Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global MicroRNA Sponge Service Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global MicroRNA Sponge Service Market Segmentation & Coverage
TABLE 2. Global MicroRNA Sponge Service Market Size, 2017-2032 (USD Million)
TABLE 3. Global MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Design Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Design Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Design Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global In Silico Design Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global In Silico Design Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global In Silico Design Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global In Vitro Design Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global In Vitro Design Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global In Vitro Design Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Functional Screening Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Functional Screening Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Functional Screening Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global High-Throughput Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global High-Throughput Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global High-Throughput Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Low-Throughput Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Low-Throughput Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Low-Throughput Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Synthesis Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Synthesis Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Synthesis Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Oligonucleotide Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Oligonucleotide Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Oligonucleotide Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Plasmid Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Plasmid Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Plasmid Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Validation Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Validation Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Validation Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Clinical Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Clinical Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Clinical Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Functional Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Functional Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Functional Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 41. Global Bioinformatics Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Bioinformatics Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Bioinformatics Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Data Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Data Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Data Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Database Access Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Database Access Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Database Access Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Microarray Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Microarray Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Microarray Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global cDNA Arrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global cDNA Arrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global cDNA Arrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Oligonucleotide Arrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Oligonucleotide Arrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Oligonucleotide Arrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Illumina Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Illumina Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Illumina Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Ion Torrent Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Ion Torrent Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Ion Torrent Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Quantitative Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Quantitative Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Quantitative Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global SYBR Green Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global SYBR Green Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global SYBR Green Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global TaqMan Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global TaqMan Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global TaqMan Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 78. Global Agricultural Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Agricultural Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Agricultural Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Biomarker Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Biomarker Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Biomarker Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Diagnostic Biomarkers Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Diagnostic Biomarkers Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Diagnostic Biomarkers Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Prognostic Biomarkers Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Prognostic Biomarkers Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Prognostic Biomarkers Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Disease Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Disease Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Disease Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Cancer Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Cancer Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Cancer Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Cardiovascular Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Cardiovascular Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Cardiovascular Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Neurological Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Neurological Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Neurological Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Clinical Trials Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Clinical Trials Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Clinical Trials Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Preclinical Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Preclinical Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Preclinical Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Government Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Government Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Government Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Universities Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Universities Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Universities Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Mid-Size Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Mid-Size Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Mid-Size Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Startups Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Startups Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Startups Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Clinical CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Clinical CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Clinical CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Preclinical CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Preclinical CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Preclinical CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Big Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Big Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Big Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Small Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Small Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Small Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global MicroRNA Sponge Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific MicroRNA Sponge Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific MicroRNA Sponge Service Market Size, by Bioinformatics Platforms, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific MicroRNA Sponge Service Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific MicroRNA Sponge Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific MicroRNA Sponge Service Market Size, by Quantitative Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific MicroRNA Sponge Service Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific MicroRNA Sponge Service Market Size, by Disease Research, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific MicroRNA Sponge Service Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific MicroRNA Sponge Service Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific MicroRNA Sponge Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific MicroRNA Sponge Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific MicroRNA Sponge Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 169. North America MicroRNA Sponge Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. North America MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 171. North America MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 172. North America MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 173. North America MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 174. North America MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 175. North America MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 176. North America MicroRNA Sponge Service Market Size, by Bioinformatics Platforms, 2017-2032 (USD Million)
TABLE 177. North America MicroRNA Sponge Service Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 178. North America MicroRNA Sponge Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 179. North America MicroRNA Sponge Service Market Size, by Quantitative Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 180. North America MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. North America MicroRNA Sponge Service Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 182. North America MicroRNA Sponge Service Market Size, by Disease Research, 2017-2032 (USD Million)
TABLE 183. North America MicroRNA Sponge Service Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 184. North America MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. North America MicroRNA Sponge Service Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 186. North America MicroRNA Sponge Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 187. North America MicroRNA Sponge Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 188. North America MicroRNA Sponge Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 189. Latin America MicroRNA Sponge Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Latin America MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 191. Latin America MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 192. Latin America MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 193. Latin America MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 194. Latin America MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 195. Latin America MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. Latin America MicroRNA Sponge Service Market Size, by Bioinformatics Platforms, 2017-2032 (USD Million)
TABLE 197. Latin America MicroRNA Sponge Service Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 198. Latin America MicroRNA Sponge Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 199. Latin America MicroRNA Sponge Service Market Size, by Quantitative Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 200. Latin America MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Latin America MicroRNA Sponge Service Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 202. Latin America MicroRNA Sponge Service Market Size, by Disease Research, 2017-2032 (USD Million)
TABLE 203. Latin America MicroRNA Sponge Service Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 204. Latin America MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Latin America MicroRNA Sponge Service Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 206. Latin America MicroRNA Sponge Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 207. Latin America MicroRNA Sponge Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 208. Latin America MicroRNA Sponge Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 209. Europe MicroRNA Sponge Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. Europe MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 211. Europe MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 212. Europe MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 213. Europe MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 214. Europe MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 215. Europe MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. Europe MicroRNA Sponge Service Market Size, by Bioinformatics Platforms, 2017-2032 (USD Million)
TABLE 217. Europe MicroRNA Sponge Service Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 218. Europe MicroRNA Sponge Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 219. Europe MicroRNA Sponge Service Market Size, by Quantitative Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 220. Europe MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. Europe MicroRNA Sponge Service Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 222. Europe MicroRNA Sponge Service Market Size, by Disease Research, 2017-2032 (USD Million)
TABLE 223. Europe MicroRNA Sponge Service Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 224. Europe MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Europe MicroRNA Sponge Service Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 226. Europe MicroRNA Sponge Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 227. Europe MicroRNA Sponge Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 228. Europe MicroRNA Sponge Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 229. Middle East MicroRNA Sponge Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 230. Middle East MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 231. Middle East MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 232. Middle East MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 233. Middle East MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 234. Middle East MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 235. Middle East MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 236. Middle East MicroRNA Sponge Service Market Size, by Bioinformatics Platforms, 2017-2032 (USD Million)
TABLE 237. Middle East MicroRNA Sponge Service Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 238. Middle East MicroRNA Sponge Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 239. Middle East MicroRNA Sponge Service Market Size, by Quantitative Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 240. Middle East MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. Middle East MicroRNA Sponge Service Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 242. Middle East MicroRNA Sponge Service Market Size, by Disease Research, 2017-2032 (USD Million)
TABLE 243. Middle East MicroRNA Sponge Service Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 244. Middle East MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Middle East MicroRNA Sponge Service Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 246. Middle East MicroRNA Sponge Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 247. Middle East MicroRNA Sponge Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 248. Middle East MicroRNA Sponge Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 249. Africa MicroRNA Sponge Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 250. Africa MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 251. Africa MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 252. Africa MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 253. Africa MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 254. Africa MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 255. Africa MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. Africa MicroRNA Sponge Service Market Size, by Bioinformatics Platforms, 2017-2032 (USD Million)
TABLE 257. Africa MicroRNA Sponge Service Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 258. Africa MicroRNA Sponge Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 259. Africa MicroRNA Sponge Service Market Size, by Quantitative Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 260. Africa MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. Africa MicroRNA Sponge Service Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 262. Africa MicroRNA Sponge Service Market Size, by Disease Research, 2017-2032 (USD Million)
TABLE 263. Africa MicroRNA Sponge Service Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 264. Africa MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Africa MicroRNA Sponge Service Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 266. Africa MicroRNA Sponge Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 267. Africa MicroRNA Sponge Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 268. Africa MicroRNA Sponge Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 269. Global MicroRNA Sponge Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 270. ASEAN MicroRNA Sponge Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. ASEAN MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 272. ASEAN MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 273. ASEAN MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 274. ASEAN MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 275. ASEAN MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 276. ASEAN MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. ASEAN MicroRNA Sponge Service Market Size, by Bioinformatics Platforms, 2017-2032 (USD Million)
TABLE 278. ASEAN MicroRNA Sponge Service Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 279. ASEAN MicroRNA Sponge Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 280. ASEAN MicroRNA Sponge Service Market Size, by Quantitative Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 281. ASEAN MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. ASEAN MicroRNA Sponge Service Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 283. ASEAN MicroRNA Sponge Service Market Size, by Disease Research, 2017-2032 (USD Million)
TABLE 284. ASEAN MicroRNA Sponge Service Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 285. ASEAN MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. ASEAN MicroRNA Sponge Service Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 287. ASEAN MicroRNA Sponge Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 288. ASEAN MicroRNA Sponge Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 289. ASEAN MicroRNA Sponge Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 290. GCC MicroRNA Sponge Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. GCC MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 292. GCC MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 293. GCC MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 294. GCC MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 295. GCC MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 296. GCC MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 297. GCC MicroRNA Sponge Service Market Size, by Bioinformatics Platforms, 2017-2032 (USD Million)
TABLE 298. GCC MicroRNA Sponge Service Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 299. GCC MicroRNA Sponge Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 300. GCC MicroRNA Sponge Service Market Size, by Quantitative Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 301. GCC MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. GCC MicroRNA Sponge Service Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 303. GCC MicroRNA Sponge Service Market Size, by Disease Research, 2017-2032 (USD Million)
TABLE 304. GCC MicroRNA Sponge Service Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 305. GCC MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. GCC MicroRNA Sponge Service Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 307. GCC MicroRNA Sponge Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 308. GCC MicroRNA Sponge Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 309. GCC MicroRNA Sponge Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 310. European Union MicroRNA Sponge Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 311. European Union MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 312. European Union MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 313. European Union MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 314. European Union MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 315. European Union MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 316. European Union MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 317. European Union MicroRNA Sponge Service Market Size, by Bioinformatics Platforms, 2017-2032 (USD Million)
TABLE 318. European Union MicroRNA Sponge Service Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 319. European Union MicroRNA Sponge Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 320. European Union MicroRNA Sponge Service Market Size, by Quantitative Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 321. European Union MicroRNA Sponge Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 322. European Union MicroRNA Sponge Service Market Size, by Biomarker Discovery, 2017-2032 (USD Million)
TABLE 323. European Union MicroRNA Sponge Service Market Size, by Disease Research, 2017-2032 (USD Million)
TABLE 324. European Union MicroRNA Sponge Service Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 325. European Union MicroRNA Sponge Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. European Union MicroRNA Sponge Service Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
TABLE 327. European Union MicroRNA Sponge Service Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 328. European Union MicroRNA Sponge Service Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 329. European Union MicroRNA Sponge Service Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 330. BRICS MicroRNA Sponge Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 331. BRICS MicroRNA Sponge Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 332. BRICS MicroRNA Sponge Service Market Size, by Design Services, 2017-2032 (USD Million)
TABLE 333. BRICS MicroRNA Sponge Service Market Size, by Functional Screening Services, 2017-2032 (USD Million)
TABLE 334. BRICS MicroRNA Sponge Service Market Size, by Synthesis Services, 2017-2032 (USD Million)
TABLE 335. BRICS MicroRNA Sponge Service Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 336. BRICS MicroRNA Sponge Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 337. BRICS MicroRNA Sponge Service Market Size, by

Companies Mentioned

  • Abcam plc
  • Addgene, Inc.
  • BioBasic Inc.
  • Biomics Biotechnologies
  • Bioneer Corporation
  • Biovector, Inc.
  • BioVision, Inc.
  • Creative Biogene
  • Exiqon A/S
  • Genechem Co., Ltd.
  • GeneCopoeia Europe
  • GeneCopoeia, Inc.
  • GenePharma Co., Ltd.
  • Genolution, Inc.
  • Genomeditech Co., Ltd.
  • GenScript Biotech Corporation
  • Horizon Discovery Group plc
  • Huaan Biotechnology Co., Ltd.
  • InvivoGen, Inc.
  • Origene Technologies, Inc.
  • RiboBio Co., Ltd.
  • Sangon Biotech Co., Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific
  • Twist Bioscience Corporation
  • VectorBuilder, Inc.

Related Topics

Related Reports

Nucleic Acid Pharmaceuticals Utilizing microRNA (miRNA) Market Outlook 2026-2038 - Product Image

Nucleic Acid Pharmaceuticals Utilizing microRNA (miRNA) Market Outlook 2026-2038

  • Report
  • Global
From
microRNA Market - Global Forecast 2026-2032 - Product Image

microRNA Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
MicroRNA Market Size, Share & Trends Analysis Report by Products & Services, Application (Cancer, Infectious Diseases, Neurological Disease), End-use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes) and Region with Growth Forecasts, 2025-2033 - Product Image

MicroRNA Market Size, Share & Trends Analysis Report by Products & Services, Application (Cancer, Infectious Diseases, Neurological Disease), End-use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes) and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
MicroRNA Market Report 2026 - Product Image

MicroRNA Market Report 2026

  • Report
  • 250 Pages
  • Global
From
microRNA (miRNA) - Global Strategic Business Report - Product Image

microRNA (miRNA) - Global Strategic Business Report

  • Report
  • 379 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.